Ratings changes by an analyst with Bank of America-Merrill Lynch elevated one medical device company’s stock today in pre-marker trading but pushed two others down. Appearing this morning on Bloomberg television, BAML’s Bob Hopkins said Wall Street isn’t foucsed enough on the July 31 investor day at Cardiovascular Systems (NSDQ:CSII), according to Seeking Alpha. The St. Paul, […]
NuVasive launches AttraX scaffold bone graft biologic
NuVasive (NSDQ:NUVA) said today it launched its AttraX scaffold ceramic-collagen bone graft in the US, touting that the scaffold’s surface has been shown to increase bone formation for faster fusion than standard ceramic bone grafts. The San Diego-based company claims that the Attrax scaffold features a unique microstructure and microporosity that are optimized for bone formation, […]
BD lifts Bard vet DeFord to CTO | Personnel Moves – June 4, 2018
Becton Dickinson (NYSE:BDX) said last Friday it is lifting former C.R. Bard science, technology and clinical affairs senior VP John DeFord to the role of chief technology officer and exec VP. Since acquiring Bard in a $24 billion deal that closed last December, DeFord has served as BD interventional segment R&D SVP, the Franklin Lakes, N.J.-based company […]
NuVasive misses EPS estimates, posts red ink in Q1
NuVasive (NSDQ:NUVA) today posted first quarter earnings that missed the Street on non-GAAP earnings per share and saw profits turn to losses. The San Diego, Calif.-based company posted losses of $27.1 million, or 53¢ per share, on sales of $260.5 million for the three months ended March 31, seeing an over 300% shift into the red […]
NuVasive touts Porous PEEK interbody implant study
NuVasive (NSDQ:NUVA) yesterday released results from a study of the company’s Porous PEEK material compared against titanium-coated PEEK and smooth PEEK material used in interbody fusion devices, touting advantages of its proprietary materials. Results from the study were published in The Spine Journal. In the study, researchers compared interbody implants composed of titanium-coated PEEK, smooth PEEK […]
Second Sight Medical taps Blake as CFO | Personnel Moves – March 27, 2018
Second Sight Medical (NSDQ:EYES) said last week it named John Blake as its new chief financial officer, succeeding Thomas Miller who has held the position since 2014. Before joining Second Sight Medical, Blake acted as finance senior VP at Tyr Pharma, and has held positions with Volcano Corp and BD Biosciences, the company said. Blake worked with […]
NuVasive bets on a victory in appeal of $28m loss to distributor
NuVasive (NSDQ:NUVA) said it is appealing a $27.8 million loss to distributor Madsen Medical in a sales poaching case, with the new case slated for April 18. Madsen Medical, a Nevada-based distributor, sued San Diego-based NuVasive in September 2013, after being fired in 2012. Owner Kris Madsen alleged that NuVasive breached its contract when it lured […]
NuVasive teases robotics offering with Street-meeting Q4
NuVasive Inc. (NSDQ:NUVA) executives yesterday teased the robot-assisted surgery solution it’s developing for spinal procedures in discussing its fourth-quarter and full-year results, which largely met the forecast on Wall Street. Chairman & CEO Greg Lucier told analysts during a conference call that San Diego-based NuVasive’s “surgical intelligence platform,” slated to be unveiled at the North American Spine […]
NuVasive levels poaching, infringement suit against Alphatec
NuVasive Inc. (NSDQ:NUVA) has filed a suit against Alphatec (NSDQ:ATEC) claiming the company hired on executives, including former COO and prez Pat Miles, with knowledge of its XLIF lateral interbody fusion procedures in an attempt to recreate the technology for its own products. In its infringement suit, submitted this week to the U.S. District Court for the Southern […]
NuVasive takes a dive on Q4 prelims
NuVasive Inc. (NSDQ:NUVA) shares took a hit today after the company posted preliminary results for the fourth quarter, disappointing analysts who were expecting better numbers from the spinal implant maker. San Diego-based NuVasive reported preliminary Q4 sales of $272 million and preliminary full-year sales of $1.03 billion, roughly in line with the consensus on Wall Street. […]
NuVasive wins expanded FDA nod, launches interbody fusion devices
NuVasive Inc. (NSDQ:NUVA) said today it won expanded FDA 510(k) clearance for its Cohere cervical interbody fusion device and that it launched the Coalesce thoracolumbar interbody fusion device. Both the launch and updated clearance comes from the company’s acquisition of Vertera Spine, which it closed last September. The Cohere and Coalesce implants use porous version of the material […]
- 1
- 2
- 3
- …
- 20
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+